Sophie Hendrix

Sophie Hendrix is a consultant currently working with PHARMACOS since March 2023, previously holding consultant roles at D4Care and quality assurance engineering at Purna Pharmaceuticals, where responsibilities included writing Risk Assessment Reports for various products. Sophie's earlier experience includes serving as a pharmaceutical expert at Eerstelijnszone Zuid-Oost Limburg, overseeing Covid-19 vaccine processes, and internships in toxicology at INSERM and Jessa Ziekenhuis, focusing on microbiome research and psychoactive substances, respectively. Sophie began a career in regulatory affairs at DAIICHI-SANKYO FRANCE, with a focus on dossier preparation and packaging modifications. Educational qualifications include a Master's degree in Toxicology from Université Paris Cité and a Master of Science in Drug Development from KU Leuven, complemented by a Bachelor's degree in Pharmaceutical Sciences from the same institution.